Sonja Eberle

659 total citations
9 papers, 474 citations indexed

About

Sonja Eberle is a scholar working on Surgery, Internal Medicine and Emergency Medical Services. According to data from OpenAlex, Sonja Eberle has authored 9 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Internal Medicine and 3 papers in Emergency Medical Services. Recurrent topics in Sonja Eberle's work include Venous Thromboembolism Diagnosis and Management (6 papers), Central Venous Catheters and Hemodialysis (3 papers) and Diagnosis and Treatment of Venous Diseases (3 papers). Sonja Eberle is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Central Venous Catheters and Hemodialysis (3 papers) and Diagnosis and Treatment of Venous Diseases (3 papers). Sonja Eberle collaborates with scholars based in Germany, United Kingdom and Switzerland. Sonja Eberle's co-authors include Kurt Ulm, Adnan Kastrati, Alban Dibra, Julinda Mehilli, Albert Schömig, José Suárez de Lezo, Sebastian Schellong, V. Hach-Wunderle, Hanno Riess and Eberhard Rabe and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Sonja Eberle

9 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonja Eberle Germany 9 361 213 165 89 64 9 474
MaryAnne Cronin United States 10 147 0.4× 159 0.7× 295 1.8× 58 0.7× 70 1.1× 18 456
Valerie Aston United States 10 134 0.4× 175 0.8× 353 2.1× 54 0.6× 33 0.5× 17 480
Enric Montserrat Spain 9 153 0.4× 103 0.5× 204 1.2× 19 0.2× 40 0.6× 13 413
John Katopodis United States 7 165 0.5× 257 1.2× 309 1.9× 51 0.6× 56 0.9× 9 504
B. Karwinski Norway 7 77 0.2× 133 0.6× 183 1.1× 73 0.8× 41 0.6× 12 322
Christine Anderson United States 7 323 0.9× 448 2.1× 473 2.9× 50 0.6× 112 1.8× 7 728
Agnieszka Janion−Sadowska Poland 11 117 0.3× 289 1.4× 104 0.6× 80 0.9× 112 1.8× 68 441
Suhas G. Parulekar United States 8 285 0.8× 94 0.4× 174 1.1× 19 0.2× 169 2.6× 12 454
G. P. Krestin Switzerland 8 180 0.5× 151 0.7× 42 0.3× 115 1.3× 107 1.7× 31 415
Steven Eisenberg United States 9 179 0.5× 142 0.7× 83 0.5× 57 0.6× 115 1.8× 13 393

Countries citing papers authored by Sonja Eberle

Since Specialization
Citations

This map shows the geographic impact of Sonja Eberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Eberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Eberle more than expected).

Fields of papers citing papers by Sonja Eberle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Eberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Eberle. The network helps show where Sonja Eberle may publish in the future.

Co-authorship network of co-authors of Sonja Eberle

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja Eberle. A scholar is included among the top collaborators of Sonja Eberle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja Eberle. Sonja Eberle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dempfle, Carl-Erik, Jürgen Koscielny, Edelgard Lindhoff‐Last, et al.. (2021). Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP). Clinical and Applied Thrombosis/Hemostasis. 27. 2975196079–2975196079. 10 indexed citations
2.
Schindewolf, Marc, Jan Beyer‐Westendorf, Sebastian Schellong, et al.. (2017). Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. Journal of the American College of Cardiology. 70(21). 2636–2648. 40 indexed citations
3.
Schindewolf, Marc, Jan Beyer‐Westendorf, Sebastian Schellong, et al.. (2014). Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT) – findings from the GerHIT multi-centre registry study. Thrombosis Research. 134(1). 29–35. 50 indexed citations
4.
Hach-Wunderle, V., Rupert Bauersachs, Sonja Eberle, et al.. (2013). Post-thrombotic syndrome 3 years after deep venous thrombosis in the Thrombosis and Pulmonary Embolism in Out-Patients (TULIPA) PLUS Registry. Journal of Vascular Surgery Venous and Lymphatic Disorders. 1(1). 5–12. 29 indexed citations
5.
Matzdorff, Axel, et al.. (2011). Advances in ITP – Therapy and Quality of Life – A Patient Survey. PLoS ONE. 6(11). e27350–e27350. 14 indexed citations
6.
Riess, Hanno, V. Hach-Wunderle, H. Gerlach, et al.. (2010). Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thrombosis and Haemostasis. 103(4). 710–717. 44 indexed citations
8.
Gerlach, H., V. Hach-Wunderle, Eberhard Rabe, et al.. (2009). Diagnosis of deep-vein thrombosis: Adherence to guidelines and outcomes in real-world health care. Thrombosis and Haemostasis. 102(12). 1234–1240. 29 indexed citations
9.
Kastrati, Adnan, Alban Dibra, Sonja Eberle, et al.. (2005). Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease. JAMA. 294(7). 819–819. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026